BIOMAT Database Logo BIOMAT Database Logo

[Granulomatous hepatitis following intravesical BCG immunotherapy for cancer of the bladder]. 1991

D Gargot, and L Alexandre, and M Sinico, and S Salmeron, and G Benoit, and C Buffet

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001749 Urinary Bladder Neoplasms Tumors or cancer of the URINARY BLADDER. Bladder Cancer,Bladder Neoplasms,Cancer of Bladder,Bladder Tumors,Cancer of the Bladder,Malignant Tumor of Urinary Bladder,Neoplasms, Bladder,Urinary Bladder Cancer,Bladder Cancers,Bladder Neoplasm,Bladder Tumor,Cancer, Bladder,Cancer, Urinary Bladder,Neoplasm, Bladder,Neoplasm, Urinary Bladder,Tumor, Bladder,Tumors, Bladder,Urinary Bladder Neoplasm
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000283 Administration, Intravesical The instillation or other administration of drugs into the bladder, usually to treat local disease, including neoplasms. Bladder Drug Administration,Drug Administration, Bladder,Instillation, Bladder,Intravesical Drug Administration,Administration, Intravesical Drug,Injections, Intravesical,Intravesical Administration,Intravesical Injection,Intravesical Instillation,Administration, Bladder Drug,Administrations, Bladder Drug,Administrations, Intravesical,Administrations, Intravesical Drug,Bladder Drug Administrations,Bladder Instillation,Bladder Instillations,Drug Administration, Intravesical,Drug Administrations, Bladder,Drug Administrations, Intravesical,Injection, Intravesical,Instillation, Intravesical,Instillations, Bladder,Instillations, Intravesical,Intravesical Administrations,Intravesical Drug Administrations,Intravesical Injections,Intravesical Instillations
D001500 BCG Vaccine An active immunizing agent and a viable avirulent attenuated strain of MYCOBACTERIUM BOVIS, which confers immunity to mycobacterial infections. It is used also in immunotherapy of neoplasms due to its stimulation of antibodies and non-specific immunity. Bacillus Calmette Guerin Vaccine,Calmette Guerin Bacillus Vaccine,Calmette's Vaccine,Calmette Vaccine,Calmettes Vaccine,Vaccine, BCG,Vaccine, Calmette's
D056486 Chemical and Drug Induced Liver Injury A spectrum of clinical liver diseases ranging from mild biochemical abnormalities to ACUTE LIVER FAILURE, caused by drugs, drug metabolites, herbal and dietary supplements and chemicals from the environment. Drug-Induced Liver Injury,Liver Injury, Drug-Induced,Acute Liver Injury, Drug-Induced,Chemically-Induced Liver Toxicity,Drug-Induced Acute Liver Injury,Drug-Induced Liver Disease,Hepatitis, Drug-Induced,Hepatitis, Toxic,Liver Injury, Drug-Induced, Acute,Toxic Hepatitis,Acute Liver Injury, Drug Induced,Chemically Induced Liver Toxicity,Chemically-Induced Liver Toxicities,Disease, Drug-Induced Liver,Diseases, Drug-Induced Liver,Drug Induced Acute Liver Injury,Drug Induced Liver Disease,Drug Induced Liver Injury,Drug-Induced Hepatitides,Drug-Induced Hepatitis,Drug-Induced Liver Diseases,Drug-Induced Liver Injuries,Hepatitides, Drug-Induced,Hepatitides, Toxic,Hepatitis, Drug Induced,Injuries, Drug-Induced Liver,Injury, Drug-Induced Liver,Liver Disease, Drug-Induced,Liver Diseases, Drug-Induced,Liver Injuries, Drug-Induced,Liver Injury, Drug Induced,Liver Toxicities, Chemically-Induced,Liver Toxicity, Chemically-Induced,Toxic Hepatitides,Toxicities, Chemically-Induced Liver,Toxicity, Chemically-Induced Liver

Related Publications

D Gargot, and L Alexandre, and M Sinico, and S Salmeron, and G Benoit, and C Buffet
Granulomatous hepatitis after intravesical BCG treatment for bladder cancer.
January 2006, Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology,
D Gargot, and L Alexandre, and M Sinico, and S Salmeron, and G Benoit, and C Buffet
Granulomatous hepatitis following intravesical BCG therapy.
October 1990, British journal of urology,
D Gargot, and L Alexandre, and M Sinico, and S Salmeron, and G Benoit, and C Buffet
Bladder contracture following intravesical BCG immunotherapy.
April 1993, Urology,
D Gargot, and L Alexandre, and M Sinico, and S Salmeron, and G Benoit, and C Buffet
Complications of Intravesical BCG Immunotherapy for Bladder Cancer.
January 2019, Radiographics : a review publication of the Radiological Society of North America, Inc,
D Gargot, and L Alexandre, and M Sinico, and S Salmeron, and G Benoit, and C Buffet
[Granulomatous prostatitis after intravesical BCG immunotherapy of superficial bladder cancer: a case report].
August 1990, Hinyokika kiyo. Acta urologica Japonica,
D Gargot, and L Alexandre, and M Sinico, and S Salmeron, and G Benoit, and C Buffet
Bilateral panuveitis following intravesical BCG immunotherapy for bladder carcinoma.
August 2010, Ocular immunology and inflammation,
D Gargot, and L Alexandre, and M Sinico, and S Salmeron, and G Benoit, and C Buffet
Disseminated BCG Infection after intravesical BCG Immunotherapy of Bladder Cancer.
October 2021, QJM : monthly journal of the Association of Physicians,
D Gargot, and L Alexandre, and M Sinico, and S Salmeron, and G Benoit, and C Buffet
Renal Tuberculosis Following Intravesical Bacillus Calmette-Guérin (BCG) Immunotherapy for the Treatment of Bladder Cancer.
April 2020, Medical archives (Sarajevo, Bosnia and Herzegovina),
D Gargot, and L Alexandre, and M Sinico, and S Salmeron, and G Benoit, and C Buffet
BCG-RIVM: a new BCG preparation for intravesical immunotherapy of superficial bladder cancer.
June 1987, Chemioterapia : international journal of the Mediterranean Society of Chemotherapy,
D Gargot, and L Alexandre, and M Sinico, and S Salmeron, and G Benoit, and C Buffet
Management of hepatic granulomatous tuberculosis complicating intravesical BCG for superficial bladder cancer.
September 2007, Canadian Urological Association journal = Journal de l'Association des urologues du Canada,
Copied contents to your clipboard!